389 related articles for article (PubMed ID: 27999207)
21. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.
Lin Y; Yang Z; Xu A; Dong P; Huang Y; Liu H; Li F; Wang H; Xu Q; Wang Y; Sun D; Zou Y; Zou X; Wang Y; Zhang D; Liu H; Wu X; Zhang M; Fu Y; Cai Z; Liu C; Wu S
Sci Rep; 2015 Mar; 5():8997. PubMed ID: 25757764
[TBL] [Abstract][Full Text] [Related]
22. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
25. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer.
Ghahhari NM; Babashah S
Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765
[TBL] [Abstract][Full Text] [Related]
26. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
27. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.
Mamoori A; Gopalan V; Smith RA; Lam AK
Biol Cell; 2016 Mar; 108(3):51-64. PubMed ID: 26712035
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells.
Xu W; Ji J; Xu Y; Liu Y; Shi L; Liu Y; Lu X; Zhao Y; Luo F; Wang B; Jiang R; Zhang J; Liu Q
Mol Carcinog; 2015 Jun; 54 Suppl 1():E148-61. PubMed ID: 25252218
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Zhu Y; Cheng Y; Guo Y; Chen J; Chen F; Luo R; Li A
Oncotarget; 2016 Feb; 7(5):5327-41. PubMed ID: 26683365
[TBL] [Abstract][Full Text] [Related]
30. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.
Xu W; Yang Z; Lu N
Cell Adh Migr; 2015; 9(4):317-24. PubMed ID: 26241004
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer stem cells, EMT and therapeutic targets.
Kotiyal S; Bhattacharya S
Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
[TBL] [Abstract][Full Text] [Related]
32. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
33. GSK-3 as potential target for therapeutic intervention in cancer.
McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Sokolosky M; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Rakus D; Gizak A; Demidenko ZN; Cocco L; Martelli AM; Cervello M
Oncotarget; 2014 May; 5(10):2881-911. PubMed ID: 24931005
[TBL] [Abstract][Full Text] [Related]
34. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation.
Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q
Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020
[TBL] [Abstract][Full Text] [Related]
35. Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions.
Doble BW; Woodgett JR
Cells Tissues Organs; 2007; 185(1-3):73-84. PubMed ID: 17587811
[TBL] [Abstract][Full Text] [Related]
36. GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells.
Duda P; Akula SM; Abrams SL; Steelman LS; Gizak A; Rakus D; McCubrey JA
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118770. PubMed ID: 32524999
[TBL] [Abstract][Full Text] [Related]
37. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
38. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
